From TokenPost · · 40s
Abbott Lowers 2026 Sales Growth Target
Abbott cuts 2026 sales growth forecast to 6% as it plans Nutrition separation by end of 2027.
In brief
Abbott cuts 2026 sales growth forecast to 6% as it plans Nutrition separation by end of 2027. Abbott lowered its 2026 comparable sales-growth outlook to 6% from 6.5%-7.5% range, targeting Nutrition separation completion by end of 2027. Originally reported by TokenPost.
Abbott's 2026 Sales Outlook
Abbott lowered its 2026 comparable sales-growth outlook to about 6% from the 6.5% to 7.5% range reaffirmed in July.
Nutrition Separation Timeline
Abbott plans to distribute shares of an independent Nutrition company to shareholders by end of 2027.
2026 Guidance Details
Abbott narrowed 2026 adjusted diluted earnings guidance to $5.50 to $5.55 per share while Nutrition separation remains targeted for completion by end of 2027.
In short
Abbott lowered its 2026 comparable sales-growth outlook to 6% from 6.5%-7.5% range, targeting Nutrition separation completion by end of 2027.
